194 related articles for article (PubMed ID: 30745818)
21. SIRT1 inhibits proliferation of pancreatic cancer cells expressing pancreatic adenocarcinoma up-regulated factor (PAUF), a novel oncogene, by suppression of β-catenin.
Cho IR; Koh SS; Malilas W; Srisuttee R; Moon J; Choi YW; Horio Y; Oh S; Chung YH
Biochem Biophys Res Commun; 2012 Jun; 423(2):270-5. PubMed ID: 22640743
[TBL] [Abstract][Full Text] [Related]
22. Brazilein, a compound isolated from Caesalpinia sappan Linn., induced growth inhibition in breast cancer cells via involvement of GSK-3β/β-Catenin/cyclin D1 pathway.
Tao LY; Li JY; Zhang JY
Chem Biol Interact; 2013 Oct; 206(1):1-5. PubMed ID: 23948132
[TBL] [Abstract][Full Text] [Related]
23. Down-regulation of β-catenin and the associated migration ability by Taiwanin C in arecoline and 4-NQO-induced oral cancer cells via GSK-3β activation.
Hsieh CH; Hsu HH; Shibu MA; Day CH; Bau DT; Ho CC; Lin YM; Chen MC; Wang SH; Huang CY
Mol Carcinog; 2017 Mar; 56(3):1055-1067. PubMed ID: 27648737
[TBL] [Abstract][Full Text] [Related]
24. MicroRNA-26b inhibits cell proliferation and cytokine secretion in human RASF cells via the Wnt/GSK-3β/β-catenin pathway.
Sun J; Yan P; Chen Y; Chen Y; Yang J; Xu G; Mao H; Qiu Y
Diagn Pathol; 2015 Jun; 10():72. PubMed ID: 26088648
[TBL] [Abstract][Full Text] [Related]
25. Anticancer effect of 20(S)-ginsenoside Rh2 on HepG2 liver carcinoma cells: Activating GSK-3β and degrading β-catenin.
Shi Q; Shi X; Zuo G; Xiong W; Li H; Guo P; Wang F; Chen Y; Li J; Chen DL
Oncol Rep; 2016 Oct; 36(4):2059-70. PubMed ID: 27573179
[TBL] [Abstract][Full Text] [Related]
26. Tumor suppressor Fbxw7 antagonizes WNT signaling by targeting β-catenin for degradation in pancreatic cancer.
Jiang JX; Sun CY; Tian S; Yu C; Chen MY; Zhang H
Tumour Biol; 2016 Oct; 37(10):13893-13902. PubMed ID: 27485116
[TBL] [Abstract][Full Text] [Related]
27. Lemur tyrosine kinase 2 silencing inhibits the proliferation of gastric cancer cells by regulating GSK-3β phosphorylation and β-catenin nuclear translocation.
Han X; Wang DZ; Yuan M; Bai WJ
Bioengineered; 2022 Mar; 13(3):6231-6243. PubMed ID: 34719320
[TBL] [Abstract][Full Text] [Related]
28. GSK3beta and beta-catenin modulate radiation cytotoxicity in pancreatic cancer.
Watson RL; Spalding AC; Zielske SP; Morgan M; Kim AC; Bommer GT; Eldar-Finkelman H; Giordano T; Fearon ER; Hammer GD; Lawrence TS; Ben-Josef E
Neoplasia; 2010 May; 12(5):357-65. PubMed ID: 20454507
[TBL] [Abstract][Full Text] [Related]
29. Inhibitory effect of selenomethionine on carcinogenesis in the model of human colorectal cancer in vitro and its link to the Wnt/β-catenin pathway.
Korbut E; Ptak-Belowska A; Brzozowski T
Acta Biochim Pol; 2018; 65(3):359-366. PubMed ID: 30016378
[TBL] [Abstract][Full Text] [Related]
30. Small molecule-based promotion of PKCα-mediated β-catenin degradation suppresses the proliferation of CRT-positive cancer cells.
Gwak J; Lee JH; Chung YH; Song GY; Oh S
PLoS One; 2012; 7(10):e46697. PubMed ID: 23071615
[TBL] [Abstract][Full Text] [Related]
31. Nerigoside suppresses colorectal cancer cell growth and metastatic potential through inhibition of ERK/GSK3β/β-catenin signaling pathway.
Wen SY; Chen YY; Deng CM; Zhang CQ; Jiang MM
Phytomedicine; 2019 Apr; 57():352-363. PubMed ID: 30831484
[TBL] [Abstract][Full Text] [Related]
32. Acetylshikonin attenuates angiotensin II-induced proliferation and motility of human brain smooth muscle cells by inhibiting Wnt/β-catenin signaling.
Li Z; Yan Z; Xu C; Dong Y; Xiong Y; Dai Y
Hum Cell; 2018 Jul; 31(3):242-250. PubMed ID: 29687375
[TBL] [Abstract][Full Text] [Related]
33. GSK-3β Governs Inflammation-Induced NFATc2 Signaling Hubs to Promote Pancreatic Cancer Progression.
Baumgart S; Chen NM; Zhang JS; Billadeau DD; Gaisina IN; Kozikowski AP; Singh SK; Fink D; Ströbel P; Klindt C; Zhang L; Bamlet WR; Koenig A; Hessmann E; Gress TM; Ellenrieder V; Neesse A
Mol Cancer Ther; 2016 Mar; 15(3):491-502. PubMed ID: 26823495
[TBL] [Abstract][Full Text] [Related]
34. Wnt3A Induces GSK-3β Phosphorylation and β-Catenin Accumulation Through RhoA/ROCK.
Kim JG; Kim MJ; Choi WJ; Moon MY; Kim HJ; Lee JY; Kim J; Kim SC; Kang SG; Seo GY; Kim PH; Park JB
J Cell Physiol; 2017 May; 232(5):1104-1113. PubMed ID: 27575935
[TBL] [Abstract][Full Text] [Related]
35. The anthelmintic drug niclosamide induces GSK-β-mediated β-catenin degradation to potentiate gemcitabine activity, reduce immune evasion ability and suppress pancreatic cancer progression.
Guo Y; Zhu H; Xiao Y; Guo H; Lin M; Yuan Z; Yang X; Huang Y; Zhang Q; Bai Y
Cell Death Dis; 2022 Feb; 13(2):112. PubMed ID: 35115509
[TBL] [Abstract][Full Text] [Related]
36. TIMMDC1 Knockdown Inhibits Growth and Metastasis of Gastric Cancer Cells through Metabolic Inhibition and AKT/GSK3β/β-Catenin Signaling Pathway.
Liu Y; Huang Y; Zhang J; Pei C; Hu J; Lyu J; Shen Y
Int J Biol Sci; 2018; 14(10):1256-1267. PubMed ID: 30123074
[TBL] [Abstract][Full Text] [Related]
37. ROCK2 regulates bFGF-induced proliferation of SH-SY5Y cells through GSK-3β and β-catenin pathway.
Boku S; Nakagawa S; Toda H; Kato A; Takamura N; Omiya Y; Inoue T; Koyama T
Brain Res; 2013 Jan; 1492():7-17. PubMed ID: 23211630
[TBL] [Abstract][Full Text] [Related]
38. Anticancer effects of baicalein on hepatocellular carcinoma cells.
Zheng YH; Yin LH; Grahn TH; Ye AF; Zhao YR; Zhang QY
Phytother Res; 2014 Sep; 28(9):1342-8. PubMed ID: 24596136
[TBL] [Abstract][Full Text] [Related]
39. Silencing DEK downregulates cervical cancer tumorigenesis and metastasis via the DEK/p-Ser9-GSK-3β/p-Tyr216-GSK-3β/β-catenin axis.
Xu X; Zou L; Yao Q; Zhang Y; Gan L; Tang L
Oncol Rep; 2017 Aug; 38(2):1035-1042. PubMed ID: 28627610
[TBL] [Abstract][Full Text] [Related]
40. G3BP1 promotes human breast cancer cell proliferation through coordinating with GSK-3β and stabilizing β-catenin.
Zhang CH; Liu H; Zhao WL; Zhao WX; Zhou HM; Shao RG
Acta Pharmacol Sin; 2021 Nov; 42(11):1900-1912. PubMed ID: 33536604
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]